Clinical trial
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06564311
Study timeline
Study start (actual)2024-08-26Date precision: day
Registry last updated2025-11-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Multiple Sclerosisunresolved
Interventions
ObexelimabDRUG
PlaceboDRUG
Sponsors & collaborators
Zenas BioPharma (USA), LLClead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06564311 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.